In eukaryotes, a nascent peptide entering the endoplasmic reticulum (ER) is scanned by two Sec61 translocon-associated large membrane machines for protein N-glycosylation and protein O-mannosylation, respectively. While the structure of the eightprotein oligosaccharyltransferase complex has been determined recently, the structures of mannosyltransferases of the PMT family, which are an integral part of ER protein homeostasis, are still unknown. Here we report cryo-EM structures of the Saccharomyces cerevisiae Pmt1−Pmt2 complex bound to a donor and an acceptor peptide at 3.2-Å resolution, showing that each subunit contains 11 transmembrane helices and a lumenal β-trefoil fold termed the MIR domain. The structures reveal the substrate recognition model and confirm an inverting mannosyl-transferring reaction mechanism by the enzyme complex. Furthermore, we found that the transmembrane domains of Pmt1 and Pmt2 share a structural fold with the catalytic subunits of oligosaccharyltransferases, confirming a previously proposed evolutionary relationship between protein O-mannosylation and protein N-glycosylation.
. It is evolutionarily conserved and plays crucial roles in numerous cellular processes, including unfolded protein O-mannosylation and protein quality control 3 . The protein O-mannosyltransferases (POMT in mammals, or PMT in yeast) catalyzes the transfer of a mannose from dolichyl phosphate-activated mannose (Dol-P-Man) to a serine or threonine residue of the proteins 4 . Dolichol is a linear, membrane-embedded molecule comprising a dozen or so isoprene repeats 5 . Dol-P-Man is synthesized at the cytosolic face of the ER membrane by the dolichol phosphate mannose synthase (DPMS), which transfers a mannose from GDP-Man to the dolichol monophosphate carrier Dol-P 6 . Dol-P-Man is then flipped to the lumenal face of the ER to serve as the mannose donor of the PMTs 7 . In contrast, protein N-glycosylation is catalyzed by the oligosaccharyltransferase (OST), an eight-protein complex embedded in the ER membrane in eukaryotes 8, 9 . The OST is an inverting glycosyltransferase that transfers a preassembled 14-sugar oligosaccharide (OS) carried by a dolichol diphosphate (Dol-PP-OS) to the NxS/T peptide motif in acceptor proteins 10 . The Dol-PP is synthesized from Dol-P by adding a phosphate at the cytosolic face of the ER. After attaching seven sugars (two GlcNAc and five mannoses), Dol-PP is flipped to the ER lumenal face where seven additional sugars (four mannoses and three glucoses) are added to become Dol-PP-OS, the ultimate donor substrate of the OSTs 11 . Therefore, the initial synthesis of the Dol-P carrier is shared between the protein N-glycosylation and protein O-mannosylation pathways, and this process is well conserved in eukaryotes. Furthermore, because OST and PMT are both physically associated with the Sec61 translocon (Fig. 1a ) 12 and their target sites may overlap (that is, NxS/T versus S/T), protein O-mannosylation and N-glycosylation are inherently interconnected and affect one another 13, 14 . In fact, PMTs are suggested to be evolutionarily related to OSTs, although structural evidence has been lacking (https://pfam.xfam.org/family/PMT) 15, 16 Protein O-mannosylation is implicated in several human diseases, including congenital muscular dystrophy, cancer metastasis and viral entry 1, 17 . The mammalian mannosyltransferase is a heterodimeric POMT1−POMT2 complex. S. cerevisiae contains six PMT proteins that can be classified into three subfamilies on the basis of sequence similarity: PMT1 (Pmt1 and Pmt5), PMT2 (Pmt2, Pmt3 and Pmt6) and PMT4 (Pmt4) 13 . Among the six, Pmt1 primarily forms a heterodimer with Pmt2, and Pmt4 homodimerizes, and together they account for the majority of the transferase activities. Simultaneous knockout of Pmt1, 2 and 4 is lethal in yeast 18, 19 . Because mannose is β-linked to the phosphate in Dol-P-Man, but is α-linked to the S/T in the acceptor proteins 20 , PMTs are inverting transferases 4, 10 . Pmt1 and Pmt2 are large, multi-pass transmembrane proteins that have 817 and 759 amino acids, respectively, with a calculated mass of 173 kDa for the heterodimer. Pmt1 and Pmt2 belong to the glycosyltransferase 39 (GT39) family (http://www. cazy.org), for which no structure has been reported 4 .
Results
Purification and structural determination of the Pmt1-Pmt2 complex. We produced the Pmt1−Pmt2 complex endogenously from baker's yeast by inserting a 3× FLAG tag to the carboxy terminus of Pmt1. We purified about 0.5 mg of the complex from 18 l of yeast culture by anti-FLAG affinity resin followed by size-exclusion chromatography. The quality and identity of the protein complex were verified by SDS-PAGE and mass spectrometry, respectively (Supplementary Note 1). To determine the structure, we first performed single-particle cryo-EM of the purified Pmt1−Pmt2 alone using a 300-kV Titan Krios microscope equipped with a K2 detector. A 3.2-Å-resolution cryo-EM three-dimensional (3D) map was derived from 581,966 particles that were selected from about 2,800 raw electron micrographs (Supplementary Note 2 and Table 1) . To understand the substrate-binding mechanism, we also performed single-particle cryo-EM of the purified Pmt1−Pmt2 in complex with a tetrapeptide acceptor (PYTV), which was shown to be an effective acceptor in an in vitro assay 21 . A 3.2-Å-resolution cryo-EM 3D map was derived from 521,848 particles that were selected from about 3,000 raw electron micrographs (Supplementary Note 3, Supplementary Fig. 1a , Supplementary Video 1 and Table 1 ). Superposition of these two maps revealed that they were highly similar except for an extra density that corresponded to the tetrapeptide in the later map ( Supplementary Fig. 1b-e) . Therefore, we will mainly discuss the map of Pmt1−Pmt2 in complex with the peptide in this paper. Most regions of the map had excellent main chain connectivity and side chain densities ( Supplementary Figs. 1 and 2) , except for the lumenal domain of Pmt2. This domain is termed the MIR domain because of its presence in the mannosyltransferase, inositol triphosphate and ryanodine receptor 22 . We subsequently determined the crystal structure of the Pmt2 MIR domain at 1.35-Å resolution ( Supplementary Fig. 3 and Table 2 ), which was fitted into the cryo-EM 3D map as a rigid body. Finally, an atomic model of the full Pmt1-Pmt2 complex was built and refined. The final model contained residues 15-749 in Pmt1 and residues 57-754 in Pmt2. The 14 amino-terminal residues and 67 C-terminal residues in Pmt1, and the 56 N-terminal residues and 5 C-terminal residues in Pmt2, were missing. Pmt1 is unique among PMTs in having a longer C-terminal tail. However, deletion of the C-terminal 86 residues (732-817) in Pmt1 did not affect its dimerization with Pmt2, nor the enzyme activity of the Pmt1−Pmt2 complex 23 , suggesting that this region is disordered and is not important for the enzyme function.
Overall structure of the Pmt1-Pmt2 complex. The overall structure is approximately 110 × 100 × 110 Å 3 and reveals a 1:1 heterodimer of Pmt1 and Pmt2 with a pseudo-twofold symmetry (Fig. 1b) . Both Pmt1 and Pmt2 contain a transmembrane region and a lumenal MIR domain. The MIR domain contains three MIR motifs forming a β-trefoil, and each MIR motif contains four β-strands and a short α-helix ( Supplementary Fig. 3 ). Remarkably, the transmembrane regions of Pmt1 and Pmt2 do not interact directly; they are held together by contacts located in a cytosolic region and a lumenal region. Such an arrangement generates a sizable rhombic cavity in the middle of the structure, which is about 20-Å long on each side. The central cavity likely allows the membrane-embedded donor substrate, Dol-P-Man, to diffuse into the catalytic site of the complex.
There are five potential N-glycosylation sites in the complex, three (N390, N513 and N743) in Pmt1 and two (N131 and N403) in Pmt2. The presence of N-glycans on PMT enzymes can affect their activity in vitro 24 . We observed two N-glycans in our EM map, one on N390 of Pmt1 and the other on N131 of Pmt2 ( Fig. 1b and Supplementary Fig. 2 ). The N513 and N743 of Pmt1 were clearly unmodified, but the N-glycosylation state of N403 in Pmt2 was undetermined because it is located in a flexible region of the structure.
Asymmetric interactions between Pmt1 and Pmt2. Pmt1 and Pmt2 each comprises 11 transmembrane helices (TMHs) plus a cytosolic N terminus and a lumenal C terminus (Fig. 1c) . The N-terminal region of Pmt1 contains an extended sequence that folds into a two-stranded β-sheet at the bottom cytosolic face of the transmembrane region, apparently stabilizing the Pmt1 structure, but the corresponding region in Pmt2 is disordered. The 11 PMT TMHs are mostly connected by short loops, except for the lumenal Supplementary  Fig. 4) . However, the MIR domain of Pmt2 rotates about 17° away from the membrane region relative to that of Pmt1. This rotation disengages the MIR domain of Pmt2 from Pmt1. Therefore, only the MIR domain of Pmt1 interacts with Pmt2 in our structure (Fig. 2a) . This interaction is mediated by stacking of W423, H482, S501 and R503 of the Pmt1 MIR domain with D571, K572 and F573 of the Pmt2 LL4. As a result, the lumenal access of Dol-P-Man to the central substrate cavity is closed from the Pmt1 MIR side and is open only from the Pmt2 MIR side. On the cytosolic side, the interface between Pmt1 and Pmt2 is mainly formed by interactions between the ends of TMH6 and TMH8, as well as between cytosolic loop 3 (CL3) of one subunit with CL4 of the other subunit. Specifically, Q612 and L613 of Pmt1 CL3 interact with W269 and L272 of Pmt2 CL4, and Q633, R634 and Q635 of Pmt2 CL3 interact with W253 and I256 of Pmt1 CL4 (Fig. 2b) . In addition, The N-terminal loop of Pmt1 contributes to this cytosolic interface via its V26 and R27 interacting with W632 and Q635 of the Pmt2 CL3. The N-terminal loop of Pmt2 is flexible and thus does not contribute to the interface. Most residues at the cytosolic interfaces between Pmt1 and Pmt2 are conserved (Supplementary Note 4) . In fact, there is an ordered lipid molecule that binds hydrophobically to TMH6 and TMH7 of Pmt1 and TMH8 of Pmt2, thereby contributing to the dimerization between Pmt1 and Pmt2 (Fig. 2b) . Fig. 2 (bottom panel) and Figs. 1b and 3a) . The donor was likely co-purified endogenously with the Pmt1−Pmt2 complex. Interestingly, the peptide acceptor and the donor were observed in different subunits; the peptide was found in Pmt2 and the donor in Pmt1. However, both the donor and acceptor substrate were located on the same (lumenal) side of Pmt1 and Pmt2 (Fig. 2a) . On the lumenal side, the above-mentioned asymmetric interaction between Pmt1 and Pmt2 has two consequences ( Fig. 2a): (1) Pmt2 has a larger and more open acceptor binding site than Pmt1 and (2) the donor-entry or product-release pathway in Pmt1 is locked closed relative to the open pathway in Pmt2. These structural features likely explain why the peptide acceptor was accommodated only in Pmt2, but not in Pmt1, and why the donor-like density was trapped in Pmt1 but not in Pmt2 during protein purification. Because the elongated donor-like density lacked the corresponding mannose moiety, we modeled the density as the enzyme product Dol-P rather than the donor substrate Dol-P-Man. The phosphate group of the reaction product had well-defined density. The yeast dolichol has 14−18 isoprene units 25 , but in our cryo-EM maps the product density was only long enough to accommodate the first seven isoprene repeats. Therefore, the second half of the yeast dolichol is likely disordered in the enzyme complex. We modeled the tetrapeptide PYTV into the identified acceptor density with the threonine side chain facing the donor binding site. By superimposing the structure of Pmt1 in complex with Dol-P on the structure of Pmt2 complexed with the acceptor peptide, we were able to examine the acceptor and donor binding sites in both Pmt1 and Pmt2 (Fig. 3a-e) .
In the Pmt1 structure, the phosphate of Dol-P is stabilized by H98, K234, R649, H654 and H655, and the acceptor threoninebinding site is formed by F76, D77, H80 and F652 (Fig. 3c,e) . All these residues in the active site are conserved among the yeast and human mannosyltransferases (Supplementary Note 4) . A K234A mutant Pmt1 retained about 80% of the wild-type enzyme activity 23 . However, the previously identified invariant DE motif, D77E78 in Pmt1 and D92E93 in Pmt2 (ref. 15 ), plays a critical role in the active site. Specifically, Pmt1 D77 (Pmt2 D92) is ideally positioned to activate the hydroxyl of the acceptor threonine, and Pmt1 E78 (Pmt2 E93) forms a salt bridge with the invariant lysine, R138 in Pmt1 and R152 in Pmt2 (Fig. 3b) . This salt bridge is located at the beginning of HH1, apparently playing a structural role to force the preceding aspartate residue (D77 in Pmt1 and D92 in Pmt2) to point towards the substrate-binding pocket and the acceptor threonine. Replacement of any residue in the DE motif in the homodimeric Pmt4, or replacing the DE motif with two alanine residues in Pmt1−Pmt2, has been shown to completely abolish the enzyme activities 15 . In contrast to the conserved threonine-binding site, the binding pocket of the other part of the acceptor peptide is not conserved among PMTs, in agreement with the fact that these enzymes do not have a preferred amino acid sequence except for the single mannose-receiving serine or threonine.
The dolichol was bound to an elongated hydrophobic groove formed by TMH6, TMH7, TMH9 and HH3, and was stabilized by W235, L238, F239, V241, T242, G245 and L252 of TMH6; A270, L274, L277 and L278 of TMH7; W545 and N548 of HH3; and M647 of TMH9 (Fig. 3e) . Given the extensive interface, individual point mutations are not expected to abolish donor binding or the enzyme activity. For example, the W253A mutant Pmt1 retained about 70% of the wild-type enzyme activity 23 . Because Dol-P-Man-the donor substrate of protein mannosyltransferases-is the product of the membrane-embedded DPMS, we compared our Pmt1 structure with the structure of DPMS (PDB 5MM1) 26 , and we found that the pockets for the dolichol-linked ligands were lined by conserved residues in both enzymes ( Supplementary Fig. 5a,b) . This observation suggests that Dol-P-Man is similarly coordinated in these different enzymes.
Conserved fold and similar catalytic mechanism between protein O-mannosylation and protein N-glycosylation. To better understand the mechanism of Pmt1-Pmt2, we performed a structurebased homology search using the online Dali server 27 . We found that the transmembrane region of Pmt1 and Pmt2 share a structural fold with the bacterial oligosaccharyltransferase PglB, the archaeal oligosaccharyltransferase AglB and the catalytic subunit Stt3 of eukaryotic OST (Fig. 4) [28] [29] [30] [31] [32] [33] . Structures of Pmt1 and PglB (PDB 5OGL) are superimposable with an r.m.s.d. of 3.2 Å (Fig. 4) . This observation confirms the previous suggestions that PMTs are evolutionarily linked to the oligosaccharyltransferases 15, 16 . Both PMTs and oligosaccharyltransferases belong to the inverting glycosyltransferases, in which the covalent bond with the anomeric carbon is on the opposite side of the sugar in the donor and the acceptor, respectively 4, 10 . Remarkably, when the structures of the two enzymes are superimposed, the acceptor and donor binding pocket in Pmt1− Pmt2 is almost in the same position as in PglB (Fig. 4) . Because the mannose moiety of the donor is missing in our structure, we did not observe a strong enough density corresponding to the Mn 2+ , although conserved residues for coordinating the divalent metal ion were present in both Pmt1 and Pmt2. The phosphate group of the modeled Dol-P in Pmt1 is near the phosphate of the Dol-PP-OS in PglB, and the acceptor threonine in Pmt2 is also close to the acceptor asparagine in PglB. Therefore, both the acceptor threonine in Pmt2 and the acceptor asparagine in PglB are located on the opposite side to their respective donors, in a similar configuration, which is consistent with the inverting transfer reaction mechanism [34] [35] [36] [37] . Another similarity between PMTs and oligosaccharyltransferases is a horizontal helix positioned right above the donor binding site. The horizontal helix in PglB is a flexible loop in the apo enzyme, perhaps allowing the large dolichol-linked oligosaccharide to diffuse into the substrate pocket, because the flexible peptide becomes an ordered helix once the dolichol-linked oligosaccharide is present in the substrate pocket 28 . The corresponding horizontal helix in Pmt1 and Pmt2 is HH3, which contributes to the binding of Dol-P. Because HH3 is ordered, even in the absence of a substrate, this helix may participate in the selection of the donor substrate, perhaps by preventing the dolichol-linked ligands with large sugar moieties (such as an OS) from accessing the substrate pocket.
Discussion
Glycosyltransferases are structurally classified into three different folds: GT-A, GT-B and GT-C. The GT-A and GT-B folds are better represented in the structural databases 10, 35, 38 . There have been very few structures determined that have the GT-C fold, due to the fact that enzymes with this fold are mostly membrane-embedded, and in many cases they form multi-subunit complexes and contain posttranslational modifications, making structural determination by traditional X-ray crystallography very difficult 29, 32 . These problems have recently been alleviated due to the advances in cryo-EM methodology 39 , as exemplified by the three cryo-EM structures of yeast and human oligosaccharyltransferases 30, 31, 33 . There are currently nine GT families in the Carbohydrate-Active Enzymes (CAZy) database that have the GT-C fold (GT22, GT39, GT50, GT57, GT58, GT59, GT66, GT83 and GT85) (http://www.cazy.org). However, all of the GT-C fold structures published so far are from the GT66 family. Therefore, the Pmt1-Pmt2 complex structure represents a structural solution of the second glycosyltransferase family (GT39).
The Pmt1-Pmt2 structure explains a large body of biochemical and mutational work done over the past decades 13 , and, in particular, the role of the invariant residues in setting up the catalytic pocket of the enzyme 4, 40 . Our structure also provides direct evidence for the evolutionary relationship of PMT proteins with OST, which was initially proposed on the basis of sequence analysis 15, 16 . The structure of the Pmt1-Pmt2 in complex with Dol-P and the tetrapeptide further confirms the inverting transfer reaction mechanism of protein O-mannosyltransferases. (green) with that of the PglB structure (PDB 5OGL, gray), which is in complex with an acceptor peptide, Mn 2+ and a nonhydrolyzable lipid-linked oligosaccharide analog, (ωZZZ)-PPC-GlcNAc (blue). The red asterisk denotes the overlapping phosphate groups and the acceptor residues in the two structures. The acceptor residues, a Thr in Pmt1−Pmt2 and an Asn in PglB are located on the opposite side of the donor group, consistent with the fact that both enzymes are inverting glycosyltransferases.
Mutations in the human mannosyltransferase POMT1−POMT2 cause congenital muscular dystrophies, characterized by abnormal glycosylation of α-dystroglycan with neuronal migration defects 17, 41 . Based on the clinical phenotypes, these diseases include WalkerWarburg syndrome, muscle-eye-brain disease and less severe forms of muscular dystrophy. We surveyed the reported POMT1−POMT2 mutations of hundreds of patients with congenital muscular dystrophies and identified dozens of missense mutations in POMT1 and POMT2 (refs. ) (Supplementary Table 1 ). Many of these mutations either reduced or abolished the enzyme activity. Yeast Pmt1 and Pmt2 share 29% and 36% identity with human POMT1 and POMT2, respectively, suggesting a similar overall structure for the human POMT1−POMT2 complex. Furthermore, most pathological mutations in human POMT1−POMT2 are conserved in yeast Pmt1−Pmt2 (Supplementary Note 4) . Therefore, we mapped the disease mutations onto the Pmt1−Pmt2 structure and found that most mutations were clustered to the ER lumenal half of the structure (Fig. 5) . Because the active site and the donor and acceptor binding pockets are on the lumenal side, their distribution pattern suggests that these mutations likely affect PMT enzymatic activity.
Unexpectedly, many disease mutations were located in the MIR domains that are away from the catalytic site, suggesting that the MIR domains may play an important role. Indeed, previous work has shown that point mutations in the Pmt1 MIR domain reduced the enzymatic activity, and deletion of the entire MIR domain of Pmt1 (304-531) nearly abolished the activity of the Pmt1−Pmt2 complex 23 . Although the exact function of the MIR domain is unknown, we performed a structure-based search and found that the MIR domain was similar to a sugar-binding mushroom lectin (PDB 2IHO) with an r.m.s.d. of 2.5 Å (Supplementary Fig. 5c ) 66 . Based on this structural homology and the fact that the MIR domain is located just above the Dol-P-Man entry or product-release path, we suggest that it may play a role in recognition of the mannose moiety of the donor substrate. More studies are needed, however, to determine the function of this domain. Our structure provides a platform for further structure-function investigations of Pmt1-Pmt2 and facilitates the future development of small molecules to modulate the enzyme activity.
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